RARRES2 and metabolic syndrome: Chemerin was identified as a chemoattractant ligand for CMKLR13, 6 but has also been found to be a novel adipokine associated with obesity and metabolic syndrome and to promote adipogenesis and regulate glucose metabolism3, 4, 7, 8.